Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maureen Higgins

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Journal of Medicinal Chemistry|May 13, 2015
New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide SynthaseWei Li, Suqing Zheng, Maureen Higgins, et al.
Redox Biology|September 1, 2020
Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activityLaura Casares, Juan Diego Unciti-Broceta, Maria Eugenia Prados, et al.
Bioorganic & Medicinal Chemistry|February 7, 2012
Synthesis and biological characterisation of sirtuin inhibitors based on the tenovinsAnna R McCarthy, Lisa Pirrie, Jonathan J Hollick, et al.
Iscience|January 17, 2022
The isoquinoline PRL-295 increases the thermostability of Keap1 and disrupts its interaction with Nrf2Sharadha Dayalan Naidu, Takafumi Suzuki, Dina Dikovskaya, et al.
Journal of Medicinal Chemistry|May 13, 2022
Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein Interaction Inhibitors with an Alternative Binding ModeNikolaos Georgakopoulos, Sandeep Talapatra, Dina Dikovskaya, et al.
Molecular Cancer Therapeutics|January 17, 2013
Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent mannerAnna R McCarthy, Marijke C C Sachweh, Maureen Higgins, et al.
Iscience|October 26, 2020
Downregulation of Keap1 Confers Features of a Fasted Metabolic StateElena V Knatko, Michael H Tatham, Ying Zhang, et al.
Redox Biology|November 16, 2025
Tetrazole-containing naphthalene bis-sulfonamide Keap1-Nrf2 interaction inhibitors with unexpected binding modesNikolaos D Georgakopoulos, Sandeep K Talapatra, Sharadha Dayalan Naidu, et al.
Redox Biology|July 27, 2025
Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new inhibitorsDonika Klenja-Skudrinja, Kevin X Ali, David Walker, et al.
Cell Cycle (Georgetown, Tex.)|October 31, 2008
Characterization, chemical optimization and anti-tumour activity of a tubulin poison identified by a p53-based phenotypic screenOliver D Staples, Jonathan J Hollick, Johanna Campbell, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Journal of Medicinal Chemistry|May 13, 2015
New Monocyclic, Bicyclic, and Tricyclic Ethynylcyanodienones as Activators of the Keap1/Nrf2/ARE Pathway and Inhibitors of Inducible Nitric Oxide SynthaseWei Li, Suqing Zheng, Maureen Higgins, et al.
Redox Biology|September 1, 2020
Isomeric O-methyl cannabidiolquinones with dual BACH1/NRF2 activityLaura Casares, Juan Diego Unciti-Broceta, Maria Eugenia Prados, et al.
Bioorganic & Medicinal Chemistry|February 7, 2012
Synthesis and biological characterisation of sirtuin inhibitors based on the tenovinsAnna R McCarthy, Lisa Pirrie, Jonathan J Hollick, et al.
Iscience|January 17, 2022
The isoquinoline PRL-295 increases the thermostability of Keap1 and disrupts its interaction with Nrf2Sharadha Dayalan Naidu, Takafumi Suzuki, Dina Dikovskaya, et al.
Journal of Medicinal Chemistry|May 13, 2022
Phenyl Bis-Sulfonamide Keap1-Nrf2 Protein-Protein Interaction Inhibitors with an Alternative Binding ModeNikolaos Georgakopoulos, Sandeep Talapatra, Dina Dikovskaya, et al.
Molecular Cancer Therapeutics|January 17, 2013
Tenovin-D3, a novel small-molecule inhibitor of sirtuin SirT2, increases p21 (CDKN1A) expression in a p53-independent mannerAnna R McCarthy, Marijke C C Sachweh, Maureen Higgins, et al.
Iscience|October 26, 2020
Downregulation of Keap1 Confers Features of a Fasted Metabolic StateElena V Knatko, Michael H Tatham, Ying Zhang, et al.
Redox Biology|November 16, 2025
Tetrazole-containing naphthalene bis-sulfonamide Keap1-Nrf2 interaction inhibitors with unexpected binding modesNikolaos D Georgakopoulos, Sandeep K Talapatra, Sharadha Dayalan Naidu, et al.
Redox Biology|July 27, 2025
Identification of a BACH1 lung cancer signature: A novel tool for understanding BACH1 biology and identifying new inhibitorsDonika Klenja-Skudrinja, Kevin X Ali, David Walker, et al.
Cell Cycle (Georgetown, Tex.)|October 31, 2008
Characterization, chemical optimization and anti-tumour activity of a tubulin poison identified by a p53-based phenotypic screenOliver D Staples, Jonathan J Hollick, Johanna Campbell, et al.
Pageof 6